Keyphrases
Nicotinamide Phosphoribosyltransferase (NAMPT)
100%
Metastatic Melanoma
38%
Immune Checkpoint Inhibitors
27%
Soluble Factors
16%
Tumor
11%
Nuclear Proteins
11%
Targeting Strategies
11%
Melanoma
11%
Epigenetics
11%
Melanoma Microenvironment
11%
Immune Response
11%
Chromatin
5%
Metabolic Reprogramming
5%
Melanoma Cells
5%
Overexpression
5%
Oncogenic Properties
5%
Tumor Burden
5%
MEK Inhibitor (MEKi)
5%
Resistance to Targeted Therapy
5%
Melanocytic Tumor
5%
Enzymatic Activity
5%
Drug Resistance
5%
Tumor Growth
5%
Therapeutic Impact
5%
Expected Outcomes
5%
Rate-limiting Enzyme
5%
Multiple Faces
5%
Transcriptional Reprogramming
5%
Redox Cofactor
5%
Environmental Inputs
5%
In Vitro-in Vivo
5%
Tumor Cells
5%
Melanoma Progression
5%
Alternative Therapeutics
5%
Druggability
5%
Omics Techniques
5%
Melanoma Model
5%
Immune Regulation
5%
Immune Evasion
5%
Intrinsic Properties
5%
Remission
5%
BRAF Inhibitor (BRAFi)
5%
Therapeutic Potential
5%
Resistance to Treatment
5%
Signaling Molecules
5%
Patient Plasma
5%
Post-transcriptional Modification
5%
Functional Role
5%
Tumor-immune System
5%
Targeted Therapy
5%
Redox Signaling
5%
Multiple Levels
5%
Functional Assay
5%
Metabolic
5%
Immune-suppressive
5%
Cell Trafficking
5%
Metabolism
5%
Protein Binding
5%
Conventional Therapy
5%
Immune Escape
5%
Immune Checkpoint Inhibitor Resistance
5%
Chromatin Binding
5%
Immune Cell Crosstalk
5%
Bound Fraction
5%
Melanoma Resistance
5%
Oncogenic Signaling
5%
Suppressive Function
5%
Immune Cells
5%
Patient Survival
5%
Xenograft
5%
Novel Combination Therapy
5%
Cell Survival
5%
Preclinical Validation
5%
Medicine and Dentistry
Nicotinamide Phosphoribosyltransferase
100%
Metastatic Melanoma
38%
Immune Checkpoint Inhibitor
33%
Melanoma
33%
Neoplasm
22%
Malignant Neoplasm
11%
Immune Response
11%
Targeted Therapy
11%
Immunocompetent Cell
11%
Nuclear Protein
11%
Carcinogenesis
11%
Cytosol
5%
Enzyme Activity
5%
Immune Evasion
5%
Tumor Progression
5%
Epigenomics
5%
Tumor Cell
5%
Cell Survival
5%
In Vitro
5%
Immunoregulation
5%
Xenograft
5%
Drug Resistance
5%
Melanoma Cell
5%
Conditioning
5%
Tamsulosin
5%
Cell Migration
5%
Signaling Molecule
5%
Combination Therapy
5%
Biochemistry, Genetics and Molecular Biology
Nicotinamide Phosphoribosyltransferase
100%
Immune Checkpoints
33%
Nuclear Protein
11%
Immune Response
11%
Immunocompetent Cell
11%
Reprogramming
11%
Carcinogenesis
11%
Drug Resistance
5%
Enzyme
5%
Metabolic Pathway
5%
Enzyme Activity
5%
Cell Migration
5%
Blood Plasma
5%
Post-Transcriptional Modification
5%
Tamsulosin
5%
Epigenomics
5%
Tumor Volume
5%
Conditioning
5%
Cell Survival
5%
Epigenetics
5%
Immunoregulation
5%
Immune Evasion
5%
Epigenetics
5%
Tumor Progression
5%